{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T23:47:38Z","timestamp":1773272858055,"version":"3.50.1"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2012,12,10]],"date-time":"2012-12-10T00:00:00Z","timestamp":1355097600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0051413","type":"journal-article","created":{"date-parts":[[2012,12,11]],"date-time":"2012-12-11T20:28:52Z","timestamp":1355257732000},"page":"e51413","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":34,"title":["Microarray-Assisted Pathway Analysis Identifies MT1X &amp; NF\u03baB as Mediators of TCRP1-Associated Resistance to Cisplatin in Oral Squamous Cell Carcinoma"],"prefix":"10.1371","volume":"7","author":[{"given":"Bo","family":"Peng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yixue","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guopei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhimin","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2012,12,10]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0140-6736(00)90011-4","article-title":"Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer","volume":"355","author":"JP Pignon","year":"2000","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1056\/NEJMra0707975","article-title":"Recent advances in head and neck cancer","volume":"359","author":"RI Haddad","year":"2008","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.canlet.2006.01.017","article-title":"The role of tamoxifen in combination with cisplatin on oral squamous cell carcinoma cell lines","volume":"245","author":"MJ Kim","year":"2007","journal-title":"Cancer Lett"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/FPC.0b013e32832e0ed7","article-title":"Platinum pathway","volume":"19","author":"S Marsh","year":"2009","journal-title":"Pharmacogenet Genomics"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"4506","DOI":"10.1111\/j.1742-4658.2010.07836.x","article-title":"Identification of carbonic anhydrase 9 as a contributor to pingyangmycin-induced drug resistance in human tongue cancer cells","volume":"277","author":"G Zheng","year":"2010","journal-title":"FEBS J"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.febslet.2010.12.045","article-title":"Cloning and functional characterization of TCRP1, a novel gene mediating resistance to cisplatin in an oral squamous cell carcinoma cell line","volume":"585","author":"Y Gu","year":"2011","journal-title":"FEBS Lett"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Peng B, Yi S, Gu Y, Zheng G, He Z (2012) Purification and biochemical characterization of a novel protein-tongue cancer chemotherapy resistance-associated protein1 (TCRP1). Protein Expr Purif.","DOI":"10.1016\/j.pep.2012.02.002"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s11010-011-0880-8","article-title":"TCRP1 promotes radioresistance of oral squamous cell carcinoma cells via Akt signal pathway","volume":"357","author":"Y Gu","year":"2011","journal-title":"Mol Cell Biochem"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1158\/1078-0432.CCR-1025-3","article-title":"Identification of genes with differential expression in acquired drug-resistant gastric cancer cells using high-density oligonucleotide microarrays","volume":"10","author":"HC Kang","year":"2004","journal-title":"Clin Cancer Res"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1074\/mcp.M500140-MCP200","article-title":"Proteins associated with Cisplatin resistance in ovarian cancer cells identified by quantitative proteomic technology and integrated with mRNA expression levels","volume":"5","author":"JJ Stewart","year":"2006","journal-title":"Mol Cell Proteomics"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/ijc.24704","article-title":"Identification of cisplatin-resistance related genes in head and neck squamous cell carcinoma","volume":"126","author":"Y Yamano","year":"2010","journal-title":"Int J Cancer"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/1471-2407-6-224","article-title":"Identification of genes associated with cisplatin resistance in human oral squamous cell carcinoma cell line","volume":"6","author":"P Zhang","year":"2006","journal-title":"BMC Cancer"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/PL00000762","article-title":"Molecular mechanisms involved in cisplatin cytotoxicity","volume":"57","author":"P Jordan","year":"2000","journal-title":"Cell Mol Life Sci"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/onc.2008.451","article-title":"Id-1 activates Akt-mediated Wnt signaling and p27Kip1 phosphorylation through PTEN inhibition","volume":"28","author":"J Lee","year":"2008","journal-title":"Oncogene"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/01.cad.0000173476.67239.3b","article-title":"PI3K\/Akt\/mTOR pathway as a target for cancer therapy","volume":"16","author":"D Morgensztern","year":"2005","journal-title":"Anti-cancer drugs"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/toxsci\/kfp230","article-title":"Metallothionein-III provides neuronal protection through activation of Nuclear Factor-\u03baB via the TrkA\/Phosphatidylinositol-3 kinase\/Akt signaling pathway","volume":"112","author":"HG Kim","year":"2009","journal-title":"Toxicological Sciences"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1124\/mol.59.4.657","article-title":"Is cisplatin-induced cell death always produced by apoptosis","volume":"59","author":"VM Gonzalez","year":"2001","journal-title":"Mol Pharmacol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0027-5107(01)00141-5","article-title":"Mechanisms of resistance to cisplatin","volume":"478","author":"M Kartalou","year":"2001","journal-title":"Mutat Res"},{"key":"ref19","first-page":"5255","article-title":"Modulation of resistance to anticancer drugs by inhibition of metallothionein synthesis","volume":"54","author":"M Satoh","year":"1994","journal-title":"Cancer Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0021-9258(17)42175-2","article-title":"Cellular responses to cisplatin. The roles of DNA-binding proteins and DNA repair","volume":"269","author":"G Chu","year":"1994","journal-title":"Journal of Biological Chemistry"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1073\/pnas.0510407103","article-title":"Zinc supplementation of young men alters metallothionein, zinc transporter, and cytokine gene expression in leukocyte populations","volume":"103","author":"TB Aydemir","year":"2006","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/0076-6879(91)05128-I","article-title":"[52] Limited proteolysis of metallothioneins","volume":"205","author":"DR Winge","year":"1991","journal-title":"Methods in enzymology"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"4703","DOI":"10.1158\/0008-5472.CAN-04-1063","article-title":"Increased expression of metallothionein is associated with irinotecan resistance in gastric cancer","volume":"64","author":"JH Chun","year":"2004","journal-title":"Cancer Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.pep.2006.12.007","article-title":"High-yield expression in Escherichia coli of soluble human MT2A with native functions","volume":"53","author":"F Yang","year":"2007","journal-title":"Protein Expr Purif"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.canlet.2008.05.034","article-title":"Pectenotoxin-2 abolishes constitutively activated NF-kappaB, leading to suppression of NF-kappaB related gene products and potentiation of apoptosis","volume":"271","author":"MO Kim","year":"2008","journal-title":"Cancer Lett"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.1242\/jcs.02579","article-title":"The NF-kappaB pathway","volume":"118","author":"PN Moynagh","year":"2005","journal-title":"J Cell Sci"},{"key":"ref27","first-page":"7081","article-title":"p53 is a determinant of X-linked inhibitor of apoptosis protein\/Akt-mediated chemoresistance in human ovarian cancer cells","volume":"63","author":"M Fraser","year":"2003","journal-title":"Cancer Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"8782","DOI":"10.1158\/0008-5472.CAN-10-1352","article-title":"BRCA1-IRIS overexpression promotes cisplatin resistance in ovarian cancer cells","volume":"70","author":"KL Chock","year":"2010","journal-title":"Cancer Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/(SICI)1097-0215(20000315)85:6<777::AID-IJC6>3.0.CO;2-D","article-title":"Role of metallothionein in cisplatin sensitivity of germ-cell tumours","volume":"85","author":"C Meijer","year":"2000","journal-title":"Int J Cancer"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000184710","article-title":"Sulfotransferase gene copy number variation: pharmacogenetics and function","volume":"123","author":"SJ Hebbring","year":"2008","journal-title":"Cytogenet Genome Res"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"7398","DOI":"10.1158\/1078-0432.CCR-05-0520","article-title":"Effect of common CYP3A4 and CYP3A5 variants on the pharmacokinetics of the cytochrome P450 3A phenotyping probe midazolam in cancer patients","volume":"11","author":"ER Lepper","year":"2005","journal-title":"Clin Cancer Res"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1124\/jpet.102.042176","article-title":"Blockage of multidrug resistance-associated proteins potentiates the inhibitory effects of arsenic trioxide on CYP1A1 induction by polycyclic aromatic hydrocarbons","volume":"304","author":"L Vernhet","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"ref33","first-page":"279","article-title":"Role of transporter genes in cisplatin resistance","volume":"22","author":"VB Konkimalla","year":"2008","journal-title":"In Vivo"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1158\/0008-5472.CAN-03-3884","article-title":"Membrane transporters and channels: role of the transportome in cancer chemosensitivity and chemoresistance","volume":"64","author":"Y Huang","year":"2004","journal-title":"Cancer Res"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"46400","DOI":"10.1074\/jbc.M107041200","article-title":"Characterization of drug transport by the human multidrug resistance protein 3 (ABCC3)","volume":"276","author":"N Zelcer","year":"2001","journal-title":"J Biol Chem"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"e1000296","DOI":"10.1371\/journal.pgen.1000296","article-title":"Disruption of AP1S1, causing a novel neurocutaneous syndrome, perturbs development of the skin and spinal cord","volume":"4","author":"A Montpetit","year":"2008","journal-title":"PLoS Genet"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.febslet.2011.11.034","article-title":"14-3-3sigma regulation by p53 mediates a chemotherapy response to 5-fluorouracil in MCF-7 breast cancer cells via Akt inactivation","volume":"586","author":"G Zheng","year":"2012","journal-title":"FEBS Lett"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0051413","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T01:18:38Z","timestamp":1643851118000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0051413"}},"subtitle":[],"editor":[{"given":"Devanand","family":"Sarkar","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,12,10]]},"references-count":37,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2012,12,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0051413","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,10]]}}}